36 participants
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-10-18
- Start Date:
- 2024-11-01
- Completion:
- 2025-12-31
Conditions
- Leukemia, Lymphocytic, Acute, Adult
Interventions
- DRUG
No Results Yet